Stay updated on FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page.

Latest updates to the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.8.0 instead of v3.7.2. The study record remains inaccessible with a 403 Forbidden message.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA sitewide NIH notice about terminology during a website transition appeared, and the displayed site revision changed from v3.7.1 to v3.7.2. The study record still shows a 403 Forbidden error.SummaryDifference1%

- Check34 days agoChange DetectedThe footer displays ClinicalTrials.gov revision v3.7.1 instead of v3.7.0 on the 403 error page.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now displays a 403 Forbidden error, preventing access to the study record details; the header and footer remain visible, indicating an access restriction rather than an update to the study data.SummaryDifference22%

- Check55 days agoChange DetectedThe page now shows Revision: v3.7.0, replacing the previous v3.6.6. This indicates a site/platform update, and does not change study details or how users interact with the page.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision: v3.6.6 replaces the previous v3.6.5 on the page, indicating a minor release update to the page's version. This change does not modify the study details or other user-facing content.SummaryDifference0.0%

Stay in the know with updates to FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page.